33 research outputs found
Engineering Fungal Nonribosomal Peptide Synthetase-like Enzymes by Heterologous Expression and Domain Swapping
A facile genetic methodology in the
filamentous fungus <i>Aspergillus nidulans</i> allowed the
exchange of various domains
in nonribosomal peptide synthase (NRPS)-like enzymes from <i>Aspergillus terreus</i>. The newly generated engineered enzymes
are capable of producing compounds with different chemical structures
than its parent enzyme <i>in vivo</i>. This work provides
insight in the programing of nonribosomal peptide biosynthesis in
filamentous fungi
Molecular Genetic Characterization of Terreic Acid Pathway in <i>Aspergillus terreus</i>
Terreic acid is a natural product
derived from 6-methylsalicylic
acid (6-MSA). A compact gene cluster for its biosynthesis was characterized.
Isolation of the intermediates and shunt products from the mutant
strains, combined with bioinformatic analyses, allowed for the proposition
of a biosynthetic pathway for terreic acid
Rational Domain Swaps Reveal Insights about Chain Length Control by Ketosynthase Domains in Fungal Nonreducing Polyketide Synthases
A facile
genetic methodology in the filamentous fungus <i>Aspergillus
nidulans</i> allowed exchange of the starter unit ACP transacylase
(SAT) domain
in the nonreduced polyketide synthase (NR-PKS) AfoE of the asperfuranone
pathway with the SAT domains from 10 other NR-PKSs. The newly created
hybrid with the NR-PKS AN3386 is able to accept a longer starter unit
in place of the native substrate to create a novel aromatic polyketide <i>in vivo</i>
Reengineering an Azaphilone Biosynthesis Pathway in <i>Aspergillus nidulans</i> To Create Lipoxygenase Inhibitors
Sclerotiorin, an azaphilone polyketide, is a bioactive natural product known to inhibit 15-lipoxygenase and many other biological targets. To readily access sclerotiorin and analogs, we developed a 2–3 step semisynthetic route to produce a variety of azaphilones starting from an advanced, putative azaphilone intermediate (<b>5</b>) overproduced by an engineered strain of <i>Aspergillus nidulans</i>. The inhibitory activities of the semisynthetic azaphilones against 15-lipoxygenase were evaluated with several compounds displaying low micromolar potency
Application of an Efficient Gene Targeting System Linking Secondary Metabolites to their Biosynthetic Genes in <i>Aspergillus terreus</i>
Nonribosomal peptides (NRPs) are natural products biosynthesized by NRP synthetases. A <i>kusA-</i>, <i>pyrG-</i> mutant strain of <i>Aspergillus terreus</i> NIH 2624 was developed that greatly facilitated the gene targeting efficiency in this organism. Application of this tool allowed us to link four major types of NRP-related secondary metabolites to their responsible genes in <i>A. terreus</i>. In addition, an NRP affecting melanin synthesis was also identified in this species
Biosynthetic Pathway for the Epipolythiodioxopiperazine Acetylaranotin in Aspergillus terreus Revealed by Genome-Based Deletion Analysis
Epipolythiodioxopiperazines
(ETPs) are a class of fungal secondary
metabolites derived from diketopiperazines. Acetylaranotin belongs
to one structural subgroup of ETPs characterized by the presence of
a seven-membered 4,5-dihydrooxepine ring. Defining the genes involved
in acetylaranotin biosynthesis should provide a means to increase
the production of these compounds and facilitate the engineering of
second-generation molecules. The filamentous fungus Aspergillus terreus produces acetylaranotin and related
natural products. Using targeted gene deletions, we have identified
a cluster of nine genes (including one nonribosomal peptide synthetase
gene, <i>ataP</i>) that is required for acetylaranotin biosynthesis.
Chemical analysis of the wild-type and mutant strains enabled us to
isolate 17 natural products from the acetylaranotin biosynthesis pathway.
Nine of the compounds identified in this study are natural products
that have not been reported previously. Our data have allowed us to
propose a biosynthetic pathway for acetylaranotin and related natural
products
Engineering Fungal Nonreducing Polyketide Synthase by Heterologous Expression and Domain Swapping
We reannotated the <i>A</i>. <i>niger</i> NR-PKS gene, e_gw1_19.204, and its downstream R domain gene, est_GWPlus_C_190476, as a single gene which we named <i>dtbA</i>. Heterologous expression of <i>dtbA</i> in <i>A</i>. <i>nidulans</i> demonstrated that DtbA protein produces two polyketides, 2,4-dihydroxy-3,5,6-trimethylbenzaldehyde (<b>1</b>) and 6-ethyl-2,4-dihydroxy-3,5-dimethylbenzaldehyde (<b>2</b>). Generation of DtbAΔR+TE chimeric PKSs by swapping the DtbA R domain with the AusA (austinol biosynthesis) or ANID_06448 TE domain enabled the production of two metabolites with carboxylic acids replacing the corresponding aldehydes
Azaphilones Inhibit Tau Aggregation and Dissolve Tau Aggregates <i>in Vitro</i>
The
aggregation of the microtubule-associated protein tau is a
seminal event in many neurodegenerative diseases, including Alzheimer’s
disease. The inhibition or reversal of tau aggregation is therefore
a potential therapeutic strategy for these diseases. Fungal natural
products have proven to be a rich source of useful compounds having
wide varieties of biological activities. We have previously screened Aspergillus nidulans secondary metabolites for their
ability to inhibit tau aggregation <i>in vitro</i> using
an arachidonic acid polymerization protocol. One aggregation inhibitor
identified was asperbenzaldehyde, an intermediate in azaphilone biosynthesis.
We therefore tested 11 azaphilone derivatives to determine their tau
assembly inhibition properties <i>in vitro</i>. All compounds
tested inhibited tau filament assembly to some extent, and four of
the 11 compounds had the advantageous property of disassembling preformed
tau aggregates in a dose-dependent fashion. The addition of these
compounds to the tau aggregates reduced both the total length and
number of tau polymers. The most potent compounds were tested in <i>in vitro</i> reactions to determine whether they interfere with
tau’s normal function of stabilizing microtubules (MTs). We
found that they did not completely inhibit MT assembly in the presence
of tau. These derivatives are very promising lead compounds for tau
aggregation inhibitors and, more excitingly, for compounds that can
disassemble pre-existing tau filaments. They also represent a new
class of anti-tau aggregation compounds with a novel structural scaffold
Elevated Bcl-2 expression in HBV pre-S2Δ cells.
<p>(A) Total RNA was isolated from Huh-7 -V, Huh-7 pre-S2Δ, and Huh-7 pre-S cells and then subjected to RT-PCR analysis with Bcl-2 and G3APDH specific primers. (B) For Huh-7 -V, Huh-7 pre-S2Δ, and Huh-7 pre-S cells, the relative levels of Bcl-2 mRNA were quantified. The data represent the mean of Bcl-2 mRNA expression level from three independent experiments. Columns, mean; bars, SD (n = 3). Significant differences (**, <i>P</i><0.01) between the control and experimental group are marked with an asterisks. (C) The cell lysates collected from three stable clones, and cell lysates were analyzed by Western blotting analysis with antibodies for hemagglutinin (HA) tag, Bcl-2, and β-actin. (D) The levels of Bcl-2 protein in the graphs were representative of three independent experiments (lower panel). Columns, mean; bars, SD (n = 3). Significant differences (**, <i>P</i><0.01) between the control and experimental group are marked with an asterisks. (E) Furthermore, expression level of Bcl-2 was determined by using Western blotting in three individual pre-S2Δ stable cell lines. (F) Expression level of Bcl-2 was enhanced by pre-S2Δ in the immortalized human hepatocyte cell line. Total cell lysate from NeHep and NeHep-pre-S2Δ were determined by Western blotting analysis with Bcl-2, pre-S, and β-actin specific antibosies.</p
The pre-S2Δ large surface protein induced expression of Bcl-2 family proteins.
<p>(A) Total cell lysate was isolated from Huh-7 -V, Huh-7 pre-S2Δ, and Huh-7 pre-S cells and then subjected to Western blotting analysis with Bcl-xL, Mcl-1, Bax, and Bad specific antibodies. (B) For Huh-7 -V, Huh-7 pre-S2Δ, and Huh-7 pre-S cells, the relative levels of Bcl-xL, Mcl-1, Bax, and Bad protein were quantified. The data represent the mean of Bcl-xL, Mcl-1, Bax, and Bad expression level from three independent experiments. Columns, mean; bars, SD (n = 3). Significant differences (*, <i>P</i><0.05) between the control and experimental group are marked with an asterisks.</p